个人简介
Federica Invernizzi 博士是米兰圣拉斐尔科学研究医院临床肝病科主任,也是该医院预防和个性化医学中心 Genos 项目的临床协调员。她还担任圣拉斐尔-图罗医院精神科的肝病学顾问。
她于 2009 年以优异成绩毕业于米兰大学内科和外科,2016 年又以优异成绩毕业于米兰大学消化内镜专业。
2012年,她获得了临床超声波学国家文凭;2020年,她获得了移植医学二级硕士学位,拥有AISF颁发的 "移植肝病专家 "专业资格;2022年,她获得了应用营养学和饮食学硕士学位。
2017年至2021年,因弗尼兹博士是米兰大学马焦雷波利克里尼科医院(Ospedale Maggiore Policlinico)卡格兰达基金会胃肠病学和肝病学组(移植肝病部)的定期合作者。
目前,她主要从事肝病学各领域的门诊工作,并在其他部门提供咨询服务,尤其对代谢/毒性和自身免疫问题感兴趣。她在管理复杂肝病患者(尤其是移植方面)和肝移植患者方面也有丰富的经验。她还从事腹部超声波检查和全科溶栓住院治疗。
在研究活动方面,她的重点是肝脏疾病,最初对移植领域特别感兴趣,后来对性别差异、自身免疫和代谢问题(代谢综合征、肥胖、肌肉疏松症、饮食失调、酒精中毒)也有兴趣。
出版物
最新出版物
Histological and serological features of acute liver injury after SARS-CoV-2 vaccination
JHEP Reports.
扩展阅读
Location and allocation: Inequity of access to liver transplantation for patients with severe acute-on-chronic liver failure in Europe
Liver Transpl 2022 Sep;28(9):1429-1440. doi: 10.1002/lt.26499. Epub 2022 Jun 16.
Vascular liver diseases: A sex-oriented analysis of the literature
Vascular liver diseases: A sex-oriented analysis of the literature.
Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice
J. Pers. Med. 2022,
扩展阅读
COVID-19 Vaccine Acceptance among Liver Transplant Recipients. Division of Gastroenterology and Endoscopy
Vaccines (Basel) 2021 Nov 11;9(11):1314. doi: 10.3390/vaccines9111314.
Special Interest Group Gender in Hepatology of the Italian Association for the Study of the Liver (AISF)
Dig Liver Dis 2021 Nov 14;S1590-8658(21)00811-2. doi: 10.1016/j.dld.2021.10.010.
Safe pregnancy after liver transplantation: Evidence from a multicenter Italian collaborative study
Dig Liver Dis. 2021 Sep 5;S1590-8658(21)00730-1.doi: 10.1016/j.dld.2021.08.013.
COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study. Gut
2021 Oct;70(10):1914-1924. doi: 10.1136/gutjnl-2021-324879.
The CCR5 and CXCR3 Pathways in Hepatitis C Virus Liver Transplanted Recipients Treated by a Direct Antiviral Agent Regimen: Informative Kinetics Profiles. Immunol
2021 Oct;34(8):542-551. doi: 10.1089/vim.2021.0035. Epub 2021 Jul 12.
Acute kidney injury and chronic kidney disease after liver transplant: A retrospective observational study
Nefrologia (Engl Ed). 2021 Jun 7:S0211-6995(21)00092-8. doi: 10.1016/j.nefro.2021.01.009.
Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)
J Hepatol. 2021 Sep;75(3):610-622. doi: 10.1016/j.jhep.2021.03.030. Epub 2021 May 2
Cost analysis of a long-term randomized controlled study in biliary duct-to-duct anastomotic stricture after liver transplantation
Transpl Int. 2021 May;34(5):825-834. doi: 10.1111/tri.13867. Epub 2021 Apr 1.
Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study
Gastroenterology. 2021 Mar;160(4):1151-1163.e3. doi: 10.1053/j.gastro.2020.11.045. Epub 2020 Dec 9.
Protective role of tacrolimus, deleterious role of age and comorbidities in liver transplant recipients with Covid-19: results from the ELITA/ELTR multi-center European study
Gastroenterology 2020 Dec 9;160(4):1151-1163.e3. doi: 10.1053/j.gastro.2020.11.045.
Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group
Hepatol Int. 2020 Dec;14(6):930-943.